AVIDIMAB

Serial Number 90030932
Registration 6368318
700

Registration Progress

Application Filed
Jul 1, 2020
Under Examination
Approved for Publication
Mar 16, 2021
Published for Opposition
Mar 16, 2021
Registered
Jun 1, 2021

Trademark Image

AVIDIMAB

Basic Information

Serial Number
90030932
Registration Number
6368318
Filing Date
July 1, 2020
Registration Date
June 1, 2021
Published for Opposition
March 16, 2021
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 1, 2021
Registration
Registered
Classes
005

Rights Holder

Scancell Limited

99
Address
Bellhouse Building
Sanders Road Oxford Science Park
Oxford OX44GD
GB

Ownership History

Scancell Limited

Original Applicant
99
Oxford GB

Scancell Limited

Owner at Publication
99
Oxford GB

Scancell Limited

Original Registrant
99
Oxford GB

Legal Representation

Attorney
Andrew D. Price

USPTO Deadlines

Next Deadline
503 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210601)
Due Date
June 01, 2027
Grace Period Ends
December 01, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

21 events
Date Code Type Description Documents
Jan 19, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 19, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 19, 2023 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Jan 19, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 19, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 19, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 1, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 16, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 16, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 24, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 8, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 5, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 5, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 4, 2021 ALIE A ASSIGNED TO LIE Loading...
Nov 2, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 7, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 7, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 7, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 6, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 30, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 4, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical, therapeutic and medicinal preparations and substances to increase the avidity of antibodies for the treatment of cancer; compounds for the treatment of cancer
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005